secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sensei Biotherapeutics, Inc. (SNSE)
CIK:        0001829802
Form:       8-K
Filed at:   2023-07-10T23:59:59+00:00
Accession:  0001193125-23-184650
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Sensei Biotherapeutics reports annual meeting results; all director nominees elected, Deloitte ratified
--------------------------------------------------------------------------------

- Bob Holmen elected with 12,245,867 votes for, 2,181,612 withheld.
- Kristian Humer elected with 11,914,421 votes for, 2,513,058 withheld.
- Deneen Vojta elected with 11,503,426 votes for, 2,924,053 withheld.
- Broker non-votes of 2,117,571 on each director proposal.
- Ratification of Deloitte & Touche as auditor passed with 16,096,264 for, 571 against, 448,215 abstained.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1829802/000119312523184650/0001193125-23-184650-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1829802/000119312523184650/d448825d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-184650

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer